Telmisartan/Hydrochlorothiazide Tablet 40/12.5 mg

Adult dose

Patients whose blood pressure is not adequately controlled with telmisartan alone should take this medication once daily with water, regardless of meals. It is recommended to adjust the dosage of each component separately before switching to this fixed-dose combination medication. When clinically appropriate, switching directly from monotherapy to this combination can be considered. - Telmisartan

Child dose

The safety and efficacy of this medication have not been established in children under 18 years.

This medication can cause serious harm to the fetus if used during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with allergies to any components or excipients, hypersensitivity to sulfonamide drugs, pregnant or nursing women, patients with bile duct obstruction or cholestasis, severe liver disease, severe kidney disease, acute glomerulonephritis, anuria, and specific electrolyte disturbances. Elderly patients, patients with hyperkalemia, mild to moderate liver dysfunction, valvular heart disease, ischemic heart disease, etc., should use this medication with caution and patients at risk of skin cancer should have their skin condition regularly checked. This medication can cause various adverse reactions, including dizziness, hypotension, gastrointestinal disturbances, skin rash, myalgia, etc., so any symptoms should be reported to a doctor immediately. This medication may interact with other drugs, so it is important to inform your doctor or pharmacist if you are taking other medications, especially when combined with lithium, potassium supplements, diuretics, non-steroidal anti-inflammatory drugs, etc. Women who are pregnant or planning to become pregnant should not use this medication, and it should not be taken while breastfeeding. In cases of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, and immediate medical attention is necessary, with treatment provided according to the symptoms. The safety and efficacy of this medication have not been established in children under 18 years old, so its use is not recommended. Elderly patients should be careful to avoid excessive blood pressure reduction when taking this medication. This medication should be stored out of reach of children and should be removed from the sealed package right before use.

Serious side effects

Urticaria, angioedema, severe swelling (edema), tightness in the chest, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rashes with high fever, blisters, peeling skin, oral/ocular mucosal pain, severe cutaneous adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough + fever, respiratory problems, yellowing of the skin or eyes (jaundice), marked fatigue, liver abnormalities (jaundice)

Mild side effects

• Dizziness
• diarrhea
• cough
• pharyngitis
• sinusitis
• hyperuricemia
• hyponatremia
• anxiety
• depression
• insomnia

This medication must be stored in a tightly sealed container to protect it from exposure to air or moisture. It is recommended to store it at room temperature, between 1 degree and 30 degrees Celsius.

Appearance

White or almost white, biconvex, round tablet

Package unit

30 tablets (10 tablets/PTPX3), 100 tablets/bottle